Bempedoic acid (CAS 738606-46-7): A Comprehensive Introduction

Bempedoic acid (CAS 738606-46-7) is a novel and promising pharmaceutical compound that has attracted significant attention in the medical and scientific communities. This article aims to provide a detailed and in – depth introduction to Bempedoic acid, covering its properties, uses, applications in various fields, and preparation methods.

Properties of Bempedoic acid

Bempedoic acid has unique chemical and physical properties. Chemically, it is a small – molecule inhibitor of ATP – citrate lyase (ACL). Structurally, it is designed to interact specifically with the ACL enzyme, which plays a crucial role in cholesterol synthesis. Physically, it exists as a white to off – white powder. It has a certain solubility profile, being sparingly soluble in water but more soluble in organic solvents such as ethanol and dimethyl sulfoxide (DMSO). The melting point of Bempedoic acid is within a specific range that is characteristic of its chemical structure. These properties are important as they influence its formulation, stability, and bioavailability.

Uses of Bempedoic acid

The primary use of Bempedoic acid is in the treatment of hypercholesterolemia. Hypercholesterolemia is a condition characterized by abnormally high levels of cholesterol in the blood, which is a major risk factor for cardiovascular diseases such as heart attacks and strokes. Bempedoic acid works by inhibiting ACL, an enzyme involved in the production of acetyl – CoA, a key precursor in cholesterol synthesis. By reducing the production of cholesterol in the liver, Bempedoic acid helps to lower low – density lipoprotein cholesterol (LDL – C) levels in the blood. This is particularly beneficial for patients who cannot tolerate statins, the most commonly prescribed cholesterol – lowering drugs, due to side effects such as muscle pain and weakness.

In addition to its use in lowering LDL – C, Bempedoic acid may also have potential in reducing triglyceride levels. Some studies have suggested that by interfering with the cholesterol synthesis pathway, it can also have an impact on triglyceride metabolism. This dual – action potential makes Bempedoic acid a valuable option in the management of dyslipidemia, a broader term that encompasses abnormal levels of cholesterol, triglycerides, and other lipids in the blood.

Applications in Various Fields

Medical Field

In the medical field, Bempedoic acid is used in clinical practice as an adjunct to diet and other lipid – modifying therapies. It is often prescribed for patients with heterozygous familial hypercholesterolemia (HeFH) or established atherosclerotic cardiovascular disease (ASCVD) who require additional LDL – C lowering. Clinical trials have shown that Bempedoic acid can significantly reduce LDL – C levels when used alone or in combination with other lipid – lowering drugs such as ezetimibe. This has led to its approval by regulatory authorities in many countries for the treatment of these specific patient populations.

Moreover, Bempedoic acid may have potential applications in the prevention of cardiovascular events. By reducing LDL – C levels, it can potentially slow down the progression of atherosclerosis, the hardening and narrowing of arteries due to the buildup of plaque. This can ultimately reduce the risk of heart attacks, strokes, and other cardiovascular complications. Ongoing research is exploring its long – term effects on cardiovascular outcomes and its role in primary and secondary prevention strategies.

Research Field

In the research field, Bempedoic acid serves as a valuable tool for studying the cholesterol synthesis pathway and the role of ACL in lipid metabolism. Scientists can use Bempedoic acid to investigate the molecular mechanisms underlying cholesterol production and how its inhibition can affect other metabolic processes. This can lead to a better understanding of the pathophysiology of dyslipidemia and the development of new therapeutic targets. Additionally, Bempedoic acid can be used in pre – clinical studies to evaluate the efficacy and safety of new drug combinations or treatment strategies for lipid disorders.

Preparation Methods of Bempedoic acid

The synthesis of Bempedoic acid typically involves a multi – step chemical process. One of the common approaches starts with the selection of appropriate starting materials. For example, a suitable aromatic compound can be used as the core structure, which is then functionalized through a series of chemical reactions. These reactions may include alkylation, acylation, and oxidation steps.

In the first step, the starting aromatic compound is often alkylated to introduce an alkyl group at a specific position. This can be achieved using an alkyl halide and a suitable base in an appropriate solvent. The reaction conditions, such as temperature, reaction time, and the ratio of reactants, need to be carefully controlled to ensure high yields and purity of the product. After alkylation, the next step may involve acylation to introduce an acyl group. This can be carried out using an acyl chloride or an anhydride in the presence of a catalyst.

Oxidation steps are also crucial in the synthesis of Bempedoic acid. Oxidizing agents such as potassium permanganate or hydrogen peroxide can be used to convert certain functional groups into the desired carboxylic acid group. The oxidation reaction needs to be carefully monitored to avoid over – oxidation and the formation of unwanted by – products. Purification steps, such as recrystallization or chromatography, are usually carried out at the end of the synthesis process to obtain Bempedoic acid in high purity.

References

• Author, A. (Year). Title of the article. Journal Name, Volume(Issue), Page numbers.
• Author, B., & Author, C. (Year). Another article title. Another Journal, Volume(Issue), Page numbers.

Inquiry Form